It has been proved in CSF by multiplexing techniques that concentrations of MMP-9 and TIMP-1 in AD patients were significantly lower than those in the subcortical vascular disease group, whereas MMP-10 levels were significantly higher in AD patients compared to healthy controls. The gene discussed is MMP9; the disease is Alzheimer disease.